Celadon still seeking finance as it draws down most of facility.
Celadon Pharmaceuticals reported on Friday that it has received £0.897m of a £1m drawdown request from its committed credit facility, with the remaining £0.1m now expected in February.
Celadon Pharmaceuticals
31 January 2025 12:14:09
Source: Sharecast
The AIM-traded company said it has sufficient working capital to operate until March, assuming expected cash receipts and continued creditor support.
Celadon said it was still seeking alternative financing options to replace its current credit facility, confirming that it was no longer in discussions with the finance provider referenced in its November update.
The firm said it was in talks with other potential lenders, adding that it would provide further updates as appropriate.
At 1138 GMT, shares in Celadon Pharmaceuticals were down 23.61% at 13.75p.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
